Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05029284 · ClinicalTrials.gov registry record · NA

Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth

A NA study of Stroke and Stroke, Ischemic, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT05029284: Completed NA study of Stroke and Stroke, Ischemic, sponsored by University of Minnesota.

NCT05029284 is a NA study of Stroke and Stroke, Ischemic that has completed, run by University of Minnesota. The registered enrollment target is 11 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05029284, a NA study of Stroke and Stroke, Ischemic, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

Adults with stroke-related disability spend more time sedentary than adults without stroke-related disability, which places them at risk for poor cardiovascular health outcomes. Few interventions are designed to reduce post-stroke sedentary time. The purpose of this research is to test whether the teleABLE (Activating Behavior for Lasting Engagement) Intervention is feasible and acceptable to adults within the first 12 months post-stroke. The hypothesis is that teleABLE can be feasibly delivered using videoconferencing within the first 12 months post-stroke. 10 participants will complete assessments and activity monitoring (activPAL micro3) at 0 (baseline) and 8 (post-intervention)-weeks. Participants will complete 12 sessions of the teleABLE intervention. Findings from this study will be used to guide the intervention protocol in the planned next phase of this research.

Primary Outcome

The count of treatment-related serious (e.g. injurious) and non-serious (e.g. fall without injury) adverse events that occur during intervention delivery will be reported.

Interventions

  • BEHAVIORAL teleABLE

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-12-20
Est. Completion 2024-03-18
Phase NA
University of Minnesota

966 total trials

What the finished NCT05029284 record still lists

NCT05029284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which teleABLE is the first listed.

NCT05029284 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05029284 about?

NCT05029284 is a clinical study titled "Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth". Adults with stroke-related disability spend more time sedentary than adults without stroke-related disability, which places them at risk for poor cardiovascular health outcomes. Few interventions are designed to reduce post-stroke sedentary time. The purpose of this research is to test whether the ...

What is the current status of trial NCT05029284?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-12-20. Estimated completion is 2024-03-18.

What conditions does trial NCT05029284 study?

This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Stroke Hemorrhagic.

What interventions are being tested in trial NCT05029284?

The interventions under investigation include: teleABLE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05029284?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05029284 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05029284's enrollment target sits among peer trials

11 409th of 454 higher than 41 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05029284, the US trial registry maintained by the National Library of Medicine. NCT05029284 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.